 X4 Pharmaceuticals, Inc. NASDAQ:XFOR Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Glenn Schulman - Vice President, Investor Relations and Corporate Communications Paula Ragan - President and Chief Executive Officer Adam Mostafa - Chief Financial Officer Diego Cadavid - Chief Medical Officer Arthur Taveras - Chief Scientific Officer Conference Call Participants Marc Frahm - Cowen Company William Wood - B. Riley Securities Trevor Howard - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Operator Greetings and welcome to X4 Pharmaceuticals First Quarter 2022 Financial and Operating Results Conference Call. 